Digital Health

The Virtual MedTech Conference offers a multitude of sessions examining the latest technological, policy and regulatory developments in digital health.

Below are just a few of the Digital Health sessions that were offered at The MedTech Conference in 2019. The 2020 conference program will be available early this summer.

View the 2019 full conference program

FDA’s New Approaches to Software Regulation: Pre-Certification and Artificial Intelligence

Advances in software and data technologies have forced the FDA to reimagine its approach to regulating these products. This panel explored the Agency’s plan to restructure its software regulations through its pre-certification pilot program and the Agency’s proposal to regulate artificial intelligence. Panelists offered insights into how companies developing medical software can position themselves to take advantage of these proposals and other regulatory challenges they face.

Diverse Perspectives on Developing and Deploying Digital Technologies

The advent of technologies which use digital platforms and artificial intelligence has the potential to significantly impact the health outcomes of patients and to change the way that health care is delivered. This session explored the various considerations that should be factored into the development and use of these types of technologies. Experts discussed the process for developing and positioning these devices, data protection and risk considerations, regulatory and legal compliance issues, market positioning and payment.

Beyond Silos: Fusing Digital Across the Enterprise

Medical device and diagnostics companies are actively embracing digital initiatives to address evolving provider and consumer demand for convenience and outcomes validation. However, most digital initiatives are consumer/customer or “front office” facing with “back office” functions operating in more traditional forms. This dichotomy of a digital front office and traditional back office presents operational and financial risk as well as consumer/customer disappointment. While clinical differentiation is essential, commercial success will increasingly depend on a manufacturer’s ability to create a cohesive and fused approach to digital transformation.

Research commissioned by Cognizant along with a survey of over 500 business and technology decision makers in the US and UK revealed significant benefits for companies that can seamlessly connect front- and back-office processes. Digital transformation is not about pilots or commercial launch of discrete apps, but transforming the enterprise to support agile management decision making to consumer/customer demands for visibility, reliability and satisfaction.

Cognizant research found:

  • Digital transformation maturity is driven by four key areas: process, organization, technology, and data insights
  • Less than 40% of companies have aligned internal teams to put the customer at the forefront of their activities
  • Back-end process teams (e.g., supply chain, finance) are the least likely to have a decision-making role in digital transformation

However, companies with higher digital maturity are 2.5 times more likely to report double digit revenue growth. This session shared the findings of the research along with case studies and practical steps companies can take.

Digital Transformation of the Medical Technology Market – the Disruptor or Enabler?

The three main pillars of digital transformation of Medical Technology industry are Care Delivery Digitization, Connected Devices and Connected Patients.

The key questions this presentation answered:

  • What are the future trends of digital transformation in the industry?
  • What is likely to shift in investments, R&D focus, partnerships and the role of various stakeholders in the new digital ecosystem?
  • What is the growth opportunity of the three pillars for the insiders and outsiders of the MedTech Industry?
  • What are the Predictions for the Digital Ecosystem in the MedTech Industry in 2020?